
A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate drug and vaccine development for …

A pilot study conducted by the University of Liverpool has found that mass rapid testing reduced COVID-19 cases in Liverpool …

The Liverpool-based vaccine-maker Sequiris is investing £40 million into the expansion of its operations in the Speke area of Liverpool. …